Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Using postmortem brain tissues from an INCL patient and tissue from the PPT1-knockout (PPT1-KO) mice that mimic INCL, we report here that PPT1 deficiency caused persistent membrane anchorage of the palmitoylated SV proteins, which hindered the recycling of the vesicle components that normally fuse with the presynaptic plasma membrane during SV exocytosis.
|
18704195 |
2008 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Using the PPT1-knockout (PPT1-KO) mice that mimic INCL, we previously reported that one mechanism of apoptosis involves endoplasmic reticulum (ER) stress-induced caspase-12 activation.
|
16644870 |
2006 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Infantile neuronal ceroid lipofuscinosis (INCL) has the earliest onset ( approximately 1.5 years of age) and is caused by a deficiency in the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1).
|
16364693 |
2006 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
These data provide new insights into the metabolism of PPT1-deficient cells and offer a basis for further studies on cellular processes causing neuronal death in INCL and other neurodegenerative diseases.
|
16542649 |
2006 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
MGD |
Infantile Neuronal Ceroid Lipofuscinosis (INCL) results from mutations in the palmitoyl protein thioesterase (PPT1, CLN1) gene and is characterized by dramatic death of cortical neurons.
|
15649713 |
2005 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
To determine the efficacy of viral-mediated gene therapy, we injected a recombinant adeno-associated virus 2 vector encoding human PPT1 (rAAV-PPT1) intracranially (I.C.) into a murine model of INCL.INCL mice given four I.C. injections of rAAV-PPT1 as newborns exhibited PPT1 activity near the injection sites and decreased secondary elevations of another lysosomal enzyme.
|
15193292 |
2004 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
The palmitoyl protein thioesterase-2 (PPT2) gene encodes a lysosomal thioesterase homologous to PPT1, which is the enzyme defective in the human disorder called infantile neuronal ceroid lipofuscinosis.
|
14528005 |
2003 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Neuronal death is common to many lysosomal storage diseases but it occurs very early in INCL and we show here that inhibition of PPT1 increases the susceptibility of these cells to apoptotic cell death.
|
11589008 |
2001 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative storage disorder in children caused by mutations in the palmitoyl protein thioesterase gene (PPT1).
|
11520175 |
2001 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
PPT1 enzyme activity was normalized in peripheral leukocytes, but remained low in the CSF and resulted only in a mild and transient amelioration of the classic INCL.
|
11673581 |
2001 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis.
|
10781062 |
2000 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
Palmitoyl-protein thioesterase-2 (PPT2) is a homolog of PPT1, the enzyme that is deficient in the lysosomal storage disorder, infantile neuronal ceroid lipofuscinosis (NCL).
|
10051407 |
1999 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding a lysosomal enzyme, palmitoyl protein thioesterase (PPT), cause infantile NCL (locus CLN1 on chromosome 1p32) or Haltia-Santavuori disease.
|
10446748 |
1999 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the palmitoyl-protein thioesterase (PPT) gene cause infantile neuronal ceroid lipofuscinosis (INCL), the clinical manifestations of which include the early loss of vision followed by deterioration of brain functions.
|
10231585 |
1999 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
This report shows the first early prenatal diagnosis of INCL performed by fluorometric enzyme analysis and mutation analysis of the CLN1 gene.
|
10416973 |
1999 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We identified a single adenine insertion at nucleotide position 169 (A169i) in the CLN1 gene in a family in which the proband suffered from an INCL-like syndrome.
|
9571187 |
1998 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We pursued the identification of the gene defective in INCL, enriched in the Finnish population by a positional cloning approach and identified mutations in the palmitoyl-protein thioesterase (PPT) gene in INCL patients.
|
9151310 |
1997 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
BEFREE |
CLN1, the gene for infantile NCL (Santavuori-Haltia disease) encodes palmitoyl protein thioesterase (PPT).
|
8803767 |
1996 |
Infantile neuronal ceroid lipofuscinosis
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|